Join the Cataract group to help and get support from people like you.
Cataract News
Related terms: Congenital Cataract
One-Third of Americans Don't Know Vision Risks From Solar Eclipse, Survey Finds
TUESDAY, April 2, 2024 – A total eclipse of the sun is coming up next week, and many folks don’t know that watching it unprotected can cause permanent eye damage, a new survey finds. Nearly 30% of A...
Eye Diseases Tied to Higher Risk for Falls, Fractures
WEDNESDAY, Jan. 3, 2024 – People with eye diseases have an increased risk for both falls and fractures when compared with those without eye diseases, according to a study published online Dec. 28...
FDA Medwatch Alert: FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products
September 12, 2023 – The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal...
AI Model Can Respond Appropriately to Ophthalmology Questions
FRIDAY, Aug. 25, 2023 – Large language models (LLMs) like ChatGPT can respond to patient-written ophthalmology questions and usually generate appropriate responses, according to a study published...
Worried About Cataracts? Here's What You Need to Know
WEDNESDAY, May 31, 2023 – Cataracts are the leading cause of blindness around the world, but surgery can restore vision. “Unlike many of the other major eye diseases, such as glaucoma or d...
FDA Medwatch Alert: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events After Receiving Eye Injections
ISSUE: At least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients ...
Icon Bioscience Receives FDA Approval for Dexycu (dexamethasone intraocular suspension) for Treating Inflammation Associated With Cataract Surgery
Newark, CA (February 12, 2018) – Icon Bioscience, Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care th...
Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients
SEATTLE--(BUSINESS WIRE)--Dec. 12, 2017-- Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...
FDA Medwatch Alert: Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin (TMV) Formulation: FDA Statement - Case of Hemorrhagic Occlusive Retinal Vasculitis
ISSUE: FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV)...
Sun Pharma Receives FDA Approval For BromSite (bromfenac ophthalmic solution)
Mumbai, April 09, 2016: Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today...
Ask a question
To post your own question to this support group, sign in or create an account.